TrialBreast cancer research and treatment2019

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.

F Lynce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.